These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1121 related items for PubMed ID: 28229191

  • 41. Performance of Positron Emission Tomography-Computed Tomography and Bone Marrow Biopsy in Detecting Bone Marrow Infiltration in Lymphoma Cases.
    Büyükşimşek M, Kolsuz İ, Yetişir AE, Tohumcuoğlu M, Oğul A, Mirili C, Paydaş S, Güney İB.
    Turk J Haematol; 2020 Nov 19; 37(4):220-225. PubMed ID: 32003552
    [Abstract] [Full Text] [Related]

  • 42. Characterizing bone marrow involvement in Hodgkin's lymphoma by FDG-PET/CT.
    Weiler-Sagie M, Kagna O, Dann EJ, Ben-Barak A, Israel O.
    Eur J Nucl Med Mol Imaging; 2014 Jun 19; 41(6):1133-40. PubMed ID: 24570095
    [Abstract] [Full Text] [Related]

  • 43. The Role of FDG- PET/CT in Detecting Bone Marrow Involvement in Childhood Solid Tumors.
    Arslantaş E, Ayçiçek A, Esen Akkas B, Tahtakesen Güçer TN, Okur Acar S, Özkan Karagenc A, Akpınar Tekgündüz S, Bayram C.
    Nuklearmedizin; 2024 Jun 19; 63(3):207-212. PubMed ID: 38190995
    [Abstract] [Full Text] [Related]

  • 44. Bone marrow disease detection with FDG-PET/CT and bone marrow biopsy during the staging of malignant lymphoma: results from a large multicentre study.
    Pelosi E, Penna D, Douroukas A, Bellò M, Amati A, Arena V, Passera R, Bisi G.
    Q J Nucl Med Mol Imaging; 2011 Aug 19; 55(4):469-75. PubMed ID: 21150862
    [Abstract] [Full Text] [Related]

  • 45. FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials.
    Kaddu-Mulindwa D, Altmann B, Held G, Angel S, Stilgenbauer S, Thurner L, Bewarder M, Schwier M, Pfreundschuh M, Löffler M, Menhart K, Grosse J, Ziepert M, Herrmann K, Dührsen U, Hüttmann A, Barbato F, Poeschel V, Hellwig D.
    Eur J Nucl Med Mol Imaging; 2021 Oct 19; 48(11):3550-3559. PubMed ID: 33928400
    [Abstract] [Full Text] [Related]

  • 46. 18F-FDG PET/CT Radiomic Analysis with Machine Learning for Identifying Bone Marrow Involvement in the Patients with Suspected Relapsed Acute Leukemia.
    Li H, Xu C, Xin B, Zheng C, Zhao Y, Hao K, Wang Q, Wahl RL, Wang X, Zhou Y.
    Theranostics; 2019 Oct 19; 9(16):4730-4739. PubMed ID: 31367253
    [Abstract] [Full Text] [Related]

  • 47. PET/CT predicts bone marrow involvement in paediatric non-Hodgkin lymphoma and may preclude the need for bone marrow biopsy in selected patients.
    Chen S, Wang S, He K, Ma C, Fu H, Wang H.
    Eur Radiol; 2018 Jul 19; 28(7):2942-2950. PubMed ID: 29383519
    [Abstract] [Full Text] [Related]

  • 48. Pre-treatment [18F]FDG PET/CT for assessing bone marrow involvement and prognosis in patients with newly diagnosed peripheral T-cell lymphoma.
    Chen J, Zhao Y.
    Hematology; 2024 Dec 19; 29(1):2325317. PubMed ID: 38465661
    [Abstract] [Full Text] [Related]

  • 49. Variety in bone marrow 18F-FDG uptake in Hodgkin lymphoma patients without lymphomatous bone marrow involvement: does it have an explanation?
    Adams HJ, de Klerk JM, Fijnheer R, Heggelman BG, Dubois SV, Nievelstein RA, Kwee TC.
    Nucl Med Commun; 2016 Jan 19; 37(1):23-9. PubMed ID: 26440567
    [Abstract] [Full Text] [Related]

  • 50. Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevance.
    Adams HJ, Kwee TC, Fijnheer R, Dubois SV, Nievelstein RA, de Klerk JM.
    Eur J Haematol; 2015 Jul 19; 95(1):83-9. PubMed ID: 25537478
    [Abstract] [Full Text] [Related]

  • 51. PET/CT Scanner and Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Diffuse Large B-Cell Lymphoma.
    El Karak F, Bou-Orm IR, Ghosn M, Kattan J, Farhat F, Ibrahim T, Jreige M, El Cheikh J, Haidar M.
    PLoS One; 2017 Jul 19; 12(1):e0170299. PubMed ID: 28099514
    [Abstract] [Full Text] [Related]

  • 52. The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET/CT: a Danish-Canadian study.
    Alzahrani M, El-Galaly TC, Hutchings M, Hansen JW, Loft A, Johnsen HE, Iyer V, Wilson D, Sehn LH, Savage KJ, Connors JM, Gascoyne RD, Johansen P, Clasen-Linde E, Brown P, Villa D.
    Ann Oncol; 2016 Jun 19; 27(6):1095-1099. PubMed ID: 27002106
    [Abstract] [Full Text] [Related]

  • 53. Consistency of FDG-PET accuracy and cost-effectiveness in initial staging of patients with Hodgkin lymphoma across jurisdictions.
    Cerci JJ, Trindade E, Buccheri V, Fanti S, Coutinho AM, Zanoni L, Linardi CC, Celli M, Delbeke D, Pracchia LF, Pitela FA, Soares J, Zinzani PL, Meneghetti JC.
    Clin Lymphoma Myeloma Leuk; 2011 Aug 19; 11(4):314-20. PubMed ID: 21816369
    [Abstract] [Full Text] [Related]

  • 54. Evaluation of bone marrow involvement in extranodal NK/T cell lymphoma by FDG-PET/CT.
    Zhou Z, Chen C, Li X, Li Z, Zhang X, Chang Y, Lu L, Cui Y, Ma Y, Zhang M.
    Ann Hematol; 2015 Jun 19; 94(6):963-7. PubMed ID: 25547320
    [Abstract] [Full Text] [Related]

  • 55. 18F-FDG PET for evaluation of bone marrow infiltration in staging of lymphoma: a meta-analysis.
    Pakos EE, Fotopoulos AD, Ioannidis JP.
    J Nucl Med; 2005 Jun 19; 46(6):958-63. PubMed ID: 15937306
    [Abstract] [Full Text] [Related]

  • 56. Bone marrow trephine biopsy in Hodgkin's lymphoma. Comparison with PET-CT scan in 65 patients.
    Lakhwani S, Cabello-García D, Allende-Riera A, Cárdenas-Negro C, Raya JM, Hernández-Garcia MT.
    Med Clin (Barc); 2018 Feb 09; 150(3):104-106. PubMed ID: 28864087
    [Abstract] [Full Text] [Related]

  • 57. Assessing bone marrow involvement in diffuse large B-cell lymphoma with 18F-FDG PET/CT: A preliminary experience at Hospital Pulau Pinang.
    Siti Maisarah MN, Mahayuddin AM, Fadzilah H.
    Med J Malaysia; 2021 Sep 09; 76(5):665-671. PubMed ID: 34508372
    [Abstract] [Full Text] [Related]

  • 58. Paediatric and adolescent Hodgkin lymphoma: information derived from diffuse organ uptake of 18 F-fluorodeoxyglucose on pre-treatment and on interim PET/CT.
    Jorgov L, Montravers F, Balogova S, Ragu C, Pacquement H, Leblanc T, Abbou S, Ducou-Lepointe H, Landman-Parker J, Talbot JN.
    Eur J Nucl Med Mol Imaging; 2016 Jul 09; 43(7):1220-30. PubMed ID: 26660144
    [Abstract] [Full Text] [Related]

  • 59. Fluorodeoxyglucose-Positron Emission Tomography Predicts Bone Marrow Involvement in the Staging of Follicular Lymphoma.
    St-Pierre F, Broski SM, LaPlant BR, Maurer MJ, Ristow K, Thanarajasingam G, Macon WR, Habermann TM, Witzig TE.
    Oncologist; 2020 Aug 09; 25(8):689-695. PubMed ID: 32319706
    [Abstract] [Full Text] [Related]

  • 60. Clinical utility of ¹⁸F FDG-PET/CT in the detection of bone marrow disease in Hodgkin's lymphoma.
    Muzahir S, Mian M, Munir I, Nawaz MK, Faruqui ZS, Mufti KA, Bashir H, Uddin N, Siddiqui N, Maaz AU, Mahmood MT.
    Br J Radiol; 2012 Aug 09; 85(1016):e490-6. PubMed ID: 22215887
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 57.